Wakamoto Pharmaceutical Co., Ltd. logo

Wakamoto Pharmaceutical Co., Ltd. (4512)

Market Closed
12 Aug, 06:00
JPX JPX
¥
270. 00
+6
+2.2727%
¥
9.89B Market Cap
- P/E Ratio
7% Div Yield
58,600 Volume
- Eps
¥ 264
Previous Close
Add Transaction
Day Range
265 271
Year Range
240 380
Want to track 4512 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Wakamoto Pharmaceutical Co., Ltd. logo
4512 Wakamoto Pharmaceutical Co., Ltd.
13 May 2026
-
-
Wakamoto Pharmaceutical Co., Ltd. logo
4512 Wakamoto Pharmaceutical Co., Ltd.
3 Feb 2026
-
-
Wakamoto Pharmaceutical Co., Ltd. logo
4512 Wakamoto Pharmaceutical Co., Ltd.
4 Nov 2025
-
-
Wakamoto Pharmaceutical Co., Ltd. logo
4512 Wakamoto Pharmaceutical Co., Ltd.
31 Jul 2025
-
-

4512 Earnings Reports FAQ

What is the earnings per share (EPS) for 4512?

EPS data for 4512 is currently not available, as Wakamoto Pharmaceutical Co., Ltd has not reported recent earnings.

What is the company's earnings growth rate?

Wakamoto Pharmaceutical Co., Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Wakamoto Pharmaceutical Co., Ltd has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Wakamoto Pharmaceutical Co., Ltd are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 4512 at this time, as Wakamoto Pharmaceutical Co., Ltd has no recent EPS data to calculate it.